ZVSA
Price:
$0.14
Market Cap:
$1.13M
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
Industry
Biotechnology
IPO Date
2022-02-11
Stock Exchange
NASDAQ
Ticker
ZVSA
According to ZyVersa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -526844571.00. This represents a change of 278.94% compared to the average of -139031963.43 of the last 4 quarters.
The mean historical Enterprise Value of ZyVersa Therapeutics, Inc. over the last ten years is 67.79M. The current -526844571.00 Enterprise Value has changed -77813.67% with respect to the historical average. Over the past ten years (40 quarters), ZVSA's Enterprise Value was at its highest in in the March 2022 quarter at 170.95M. The Enterprise Value was at its lowest in in the September 2025 quarter at -516599203.34.
Average
67.79M
Median
8.45M
Minimum
-2251491.00
Maximum
169.15M
Discovering the peaks and valleys of ZyVersa Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.16%
Maximum Annual Enterprise Value = 169.15M
Minimum Annual Increase = -126.64%
Minimum Annual Enterprise Value = -2251491.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | -354289.02 | -84.26% |
| 2023 | -2251491.00 | -126.64% |
| 2022 | 8.45M | -95.00% |
| 2021 | 169.15M | 3.16% |
The current Enterprise Value of ZyVersa Therapeutics, Inc. (ZVSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.95M
5-year avg
67.79M
10-year avg
67.79M
ZyVersa Therapeutics, Inc.’s Enterprise Value is less than Hepion Pharmaceuticals, Inc. (-1855515.00), less than CDT Equity Inc. (444.36K), less than Enveric Biosciences, Inc. (732.11K), less than Longevity Health Holdings Inc. (58.39K), less than NewGenIvf Group Limited (3.11M), less than SCWorx Corp. (247.33K), less than Indaptus Therapeutics, Inc. (-2307685.00), less than Jasper Therapeutics, Inc. (-7043957.00), less than Onconetix, Inc. (1.04M), less than Silexion Therapeutics Ltd. (1.94M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -1855515.00 | $697.22K | |
| 444.36K | $2.41M | |
| 732.11K | $3.58M | |
| 58.39K | $548.98K | |
| 3.11M | $537.60K | |
| 247.33K | $930.89K | |
| -2307685.00 | $3.82M | |
| -7043957.00 | $30.31M | |
| 1.04M | $1.71M | |
| 1.94M | $1.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZyVersa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ZyVersa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ZyVersa Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?
What is the 3-year average Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?
What is the 5-year average Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?
How does the current Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA) compare to its historical average?